Bullish Options Trading Picks Up on Twitter Before Earnings

Analysts, meanwhile, remain skeptical of TWTR stock

by Karee Venema

Published on Feb 6, 2019 at 11:31 AM

With Twitter Inc (NYSE:TWTR) set to report fourth-quarter earnings ahead of open tomorrow, Feb. 7, call volume is accelerated on the social media stock today. At last check, around 40,000 calls have traded on TWTR stock -- two times what's typically seen at this point -- with the weekly 2/8 options series in focus.

More specifically, the weekly 2/8 35-strike call is most active, with 6,452 contracts on the tape. It looks like some speculators may be buying to open these calls for a volume-weighted average price of $1.82. If this is the case, breakeven for the call buyers at the close this Friday, Feb. 8, is $36.82 (strike plus premium paid).

This bullish positioning is hardly new for Twitter options traders. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day call/put volume ratio of 3.79 ranks in the 88th annual percentile, meaning calls have been bought to open over puts at a faster-than-usual pace.

Elsewhere on Wall Street, though, 18 of 25 analysts maintain a "hold" or "strong sell" rating on Twitter. Plus, the average 12-month price target of $34.45 is roughly in line with the stock's current perch.

Short interest, meanwhile, plunged 44.3% during the Dec. 15 and Jan. 15 reporting periods, which likely helped fuel the stock's strong rally off its Dec. 24 low of $26.26. Whatever the reason, TWTR stock is up almost 30% since finding a familiar floor in this region, and is testing its 200-day moving average today -- up 0.03% at $34.40.

twtr stock daily price chart feb 6

For tomorrow's trading, the options market is pricing in a post-earnings move of 19.5%,  more than the 12.9% next-day move TWTR stock has averaged over the last eight quarters. Four of those earnings reactions have been positive -- including a 15.5% jump last quarter and 12.2% pop this time last year -- and four have been negative, including a 20.5% plunge last July.

SAGE Therapeutics Stock Hot Ahead of Earnings
The drug name is scheduled to report on Tuesday
Bear Signal Flashing for This Healthcare Stock Before Earnings
At least four analysts have issued price-target cuts on the stock this week
Signal Says This Retail Stock's on Sale
The shares pulled back this week on news of a Levi Strauss IPO
START YOUR DAY SMARTER.

Get Schaeffer's pre-market news bulletin every morning before the bell rings.
It's free to sign up.


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
3 of Today's Worst Nasdaq Stocks
The stocks are sitting out today's rally in the broader equities market
2019 Rally Continues for Stock Market
The Nasdaq is eyeing its longest weekly win streak since 2016
How American Lithium Tech May Be Poised for 614% Growth
A new lithium technology could change the face of lithium production forever.